Walvax Biotechnology announces director Huang Zhen's resignation

Walvax Biotechnology Co., Ltd. (SZSE:300142) announced the resignation of Director Huang Zhen from the fifth session of the board of directors, effective April 30, 2025. The resignation is attributed to personal reasons, and Huang Zhen will no longer hold any positions within the company or its subsidiaries. His original term was set to expire on October 12, 2025. Walvax Biotechnology confirmed that Huang Zhen's departure will not reduce the board below the legal minimum or significantly impact operations. As of the announcement date, Huang Zhen held 17,698,729 shares in Walvax Biotechnology and will continue to adhere to regulations regarding shareholding changes. The company expressed gratitude for Huang Zhen's contributions during his tenure as a director.